CohBar Inc (OTCPK:CWBR)
$ 0.5 -0.014 (-2.72%) Market Cap: 1.45 Mil Enterprise Value: -10.86 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 31/100

CohBar, Inc. - Special Call Transcript

Nov 06, 2020 / 07:00PM GMT
Release Date Price: $29.04 (-0.52%)
Operator

Good afternoon, and welcome to the CohBar KOL call. (Operator Instructions) As a reminder, this conference is being recorded, and a replay will be made available on the CohBar website following the event.

I'd now like to turn the call over to your host, Steve Engle, Chief Executive Officer of CohBar. Please go ahead, sir.

Steven B. Engle
CohBar, Inc. - CEO & Director

Thank you, Sarah. Welcome, everyone. Thank you for joining us. CohBar is developing compounds based on breakthrough mitochondrial science that represents a major new source of therapeutics for multiple diseases. Today, we are very pleased to discuss our novel Antifibrotic Peptides for IPF and other fibrotic diseases. And with the help of Dr. Maher, who is a world-class medical expert and clinical trialist, the need for new approaches in idiopathic pulmonary fibrosis.

Next slide, please. Forward-looking statements apply.

Next slide, please. CohBar is the leader in developing a new class therapeutics -- mitochondrial-based therapeutics. Our Chief Science Officer, Ken

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot